DOUYU INTERNATIONAL HOLD-ADR (DOYU)

US25985W2044 - ADR

10.85  +0.37 (+3.53%)

Fundamental Rating

4

DOYU gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. While DOYU has a great health rating, there are worries on its profitability. DOYU is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year DOYU was profitable.
The reported net income has been mixed in the past 5 years: DOYU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: DOYU reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -0.82%, DOYU is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
DOYU's Return On Equity of -1.02% is fine compared to the rest of the industry. DOYU outperforms 69.70% of its industry peers.
Industry RankSector Rank
ROA -0.82%
ROE -1.02%
ROIC N/A
ROA(3y)-2.54%
ROA(5y)-0.35%
ROE(3y)-3.31%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of DOYU has declined.
DOYU's Gross Margin of 12.12% is on the low side compared to the rest of the industry. DOYU is outperformed by 84.85% of its industry peers.
In the last couple of years the Gross Margin of DOYU has grown nicely.
DOYU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-49.73%
PM growth 5YN/A
GM growth 3Y-8.7%
GM growth 5Y24.51%

8

2. Health

2.1 Basic Checks

DOYU does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOYU has less shares outstanding than it did 1 year ago.
DOYU has less shares outstanding than it did 5 years ago.
There is no outstanding debt for DOYU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

DOYU has an Altman-Z score of 1.64. This is a bad value and indicates that DOYU is not financially healthy and even has some risk of bankruptcy.
DOYU has a Altman-Z score (1.64) which is comparable to the rest of the industry.
There is no outstanding debt for DOYU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.64
ROIC/WACCN/A
WACC7.54%

2.3 Liquidity

DOYU has a Current Ratio of 4.39. This indicates that DOYU is financially healthy and has no problem in meeting its short term obligations.
DOYU's Current ratio of 4.39 is amongst the best of the industry. DOYU outperforms 92.42% of its industry peers.
DOYU has a Quick Ratio of 4.39. This indicates that DOYU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.39, DOYU belongs to the top of the industry, outperforming 92.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.39
Quick Ratio 4.39

3

3. Growth

3.1 Past

DOYU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1466.67%, which is quite impressive.
The earnings per share for DOYU have been decreasing by -37.87% on average. This is quite bad
The Revenue for DOYU has decreased by -22.20% in the past year. This is quite bad
The Revenue has been growing by 8.64% on average over the past years. This is quite good.
EPS 1Y (TTM)1466.67%
EPS 3Y-37.87%
EPS 5YN/A
EPS Q2Q%-160%
Revenue 1Y (TTM)-22.2%
Revenue growth 3Y-16.8%
Revenue growth 5Y8.64%
Sales Q2Q%-21.78%

3.2 Future

DOYU is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.75% yearly.
The Revenue is expected to decrease by -8.62% on average over the next years.
EPS Next Y-263.87%
EPS Next 2Y-74.9%
EPS Next 3Y-31.75%
EPS Next 5YN/A
Revenue Next Year-23.67%
Revenue Next 2Y-14.27%
Revenue Next 3Y-8.62%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.95 indicates a correct valuation of DOYU.
DOYU's Price/Earnings ratio is rather cheap when compared to the industry. DOYU is cheaper than 83.33% of the companies in the same industry.
DOYU's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.28.
DOYU is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 16.95
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

DOYU's earnings are expected to decrease with -31.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-74.9%
EPS Next 3Y-31.75%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.66%, DOYU is a good candidate for dividend investing.
DOYU's Dividend Yield is rather good when compared to the industry average which is at 3.70. DOYU pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, DOYU pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.66%

5.2 History

DOYU does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y-74.9%
EPS Next 3Y-31.75%

DOUYU INTERNATIONAL HOLD-ADR

NASDAQ:DOYU (1/14/2025, 8:00:01 PM)

10.85

+0.37 (+3.53%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-20 2024-11-20/bmo
Earnings (Next)N/A N/A
Inst Owners1.95%
Inst Owner Change0%
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap343.25M
Analysts45.45
Price Target8.59 (-20.83%)
Short Float %0.23%
Short Ratio6.91
Dividend
Industry RankSector Rank
Dividend Yield 12.66%
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1649.1%
Min EPS beat(2)-3386.29%
Max EPS beat(2)88.08%
EPS beat(4)3
Avg EPS beat(4)-534.14%
Min EPS beat(4)-3386.29%
Max EPS beat(4)1141.83%
EPS beat(8)6
Avg EPS beat(8)-179.86%
EPS beat(12)9
Avg EPS beat(12)-112.98%
EPS beat(16)12
Avg EPS beat(16)-79.33%
Revenue beat(2)1
Avg Revenue beat(2)-10.59%
Min Revenue beat(2)-24.04%
Max Revenue beat(2)2.85%
Revenue beat(4)3
Avg Revenue beat(4)-4.14%
Min Revenue beat(4)-24.04%
Max Revenue beat(4)2.85%
Revenue beat(8)5
Avg Revenue beat(8)-1.98%
Revenue beat(12)7
Avg Revenue beat(12)-1.42%
Revenue beat(16)9
Avg Revenue beat(16)-1.17%
PT rev (1m)2.89%
PT rev (3m)21.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)12.85%
EPS NY rev (3m)42.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.12%
Revenue NY rev (3m)3.06%
Valuation
Industry RankSector Rank
PE 16.95
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)0.64
EY5.9%
EPS(NY)-0.68
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.93
BVpS28.42
TBVpS27.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -1.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.12%
FCFM N/A
ROA(3y)-2.54%
ROA(5y)-0.35%
ROE(3y)-3.31%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-49.73%
PM growth 5YN/A
GM growth 3Y-8.7%
GM growth 5Y24.51%
F-ScoreN/A
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.39
Quick Ratio 4.39
Altman-Z 1.64
F-ScoreN/A
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)60.84%
Cap/Depr(5y)78.42%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1466.67%
EPS 3Y-37.87%
EPS 5YN/A
EPS Q2Q%-160%
EPS Next Y-263.87%
EPS Next 2Y-74.9%
EPS Next 3Y-31.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.2%
Revenue growth 3Y-16.8%
Revenue growth 5Y8.64%
Sales Q2Q%-21.78%
Revenue Next Year-23.67%
Revenue Next 2Y-14.27%
Revenue Next 3Y-8.62%
Revenue Next 5YN/A
EBIT growth 1Y-131.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-173.18%
EBIT Next 3Y0.97%
EBIT Next 5YN/A
FCF growth 1Y30.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.7%
OCF growth 3YN/A
OCF growth 5YN/A